“Efficacy and safety of tralokinumab plus topical corticosteroids in patients with severe atopic dermatitis and prior history of dupilumab treatment: a post hoc subgroup analysis from ECZTRA 7 trial”, J of Skin, vol. 5, no. 6, p. s60, Nov. 2021, doi: 10.25251/skin.5.supp.60.